When does Abbott (ABT.SW) report earnings and why does it matter?

Abbott (ABT.SW) reports on **22 Jan 2026**. The result matters because diagnostics and device segment guidance can move the stock intraday. Expect reactions to revenue, EPS, and forward commentary that affect short-term trading and price discovery.

What are the key valuation metrics for ABT.SW stock?

ABT.SW trades at **PE 15.82** with **EPS 6.32** and dividend yield **1.94%**. Free cash flow per share is **3.95** and ROE is **28.24%**, showing cash strength and efficient capital returns versus peers.

What does Meyka AI forecast for ABT.SW stock after earnings?

Meyka AI's forecast model projects **CHF110.78** for the quarter and **CHF91.69** for the year. Versus **CHF100.00**, that implies +10.78% and -8.31% respectively. Forecasts are model-based projections and not guarantees.

How should traders position for ABT.SW earnings intraday?

Keep positions size-limited, set clear stop levels, and watch volume for confirmation. A surprise beat may push price above the 50-day average **99.24**, while a miss could test the 200-day **102.26** or lower. Trade plans should reflect volatility risk.

CH Stocks

ABT.SW Abbott Laboratories (SIX) at CHF100.00 pre-earnings: watch 22 Jan for guidance

ByHuzaifa Zahoor January 19, 2026

ABT.SW stock trades at CHF100.00 on the SIX market on 19 Jan 2026 as investors prepare for Abbott Laboratories’ earnings on 22 Jan 2026. The company reports with a trailing EPS 6.32 and PE 15.82, leaving room for reaction if diagnostics or devices miss or beat estimates. We focus on near-term catalysts, valuation vs the healthcare sector, and what a single beat or miss could mean for intraday trading and short-term targets.